Prognostic value of measurable residual disease monitoring by next-generation sequencing before and after allogeneic hematopoietic cell transplantation in acute myeloid leukemia

Given limited studies on next-generation sequencing-based measurable residual disease (NGS-MRD) in acute myeloid leukemia (AML) patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT), we longitudinally collected samples before and after allo-HSCT from two independent prospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hee-Je, Kim, Yonggoo, Kang, Dain, Kim, Hoon Seok, Lee, Jong-Mi, Kim, Myungshin, Cho, Byung-Sik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178334/
https://www.ncbi.nlm.nih.gov/pubmed/34088902
http://dx.doi.org/10.1038/s41408-021-00500-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178334/
https://www.ncbi.nlm.nih.gov/pubmed/34088902
http://dx.doi.org/10.1038/s41408-021-00500-9

Ejemplares similares